Related Experiment Video
Updated: May 29, 2025

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Oncogenic non-V600 mutations evade the regulatory machinery of RAF including the Cdc37/Hsp90 chaperone and the 14-3-3
Xiaoyu Wan1, Jiajun Yap1,2, Junjun Chen1
1The Division of Cellular and Molecular Research, National Cancer Centre Singapore, Singapore General Hospital, 30 Hospital Boulevard, Singapore 168583.
Abstract:
The Ser/Thr kinase RAF, particularly BRAF isoform is a dominant target of oncogenic mutations and many mutations have been identified in various cancers. However, how these mutations except V600E evade the regulatory machinery of RAF protein and hence trigger its oncogenicity remains unclear. Methods: In this study, we used mutagenesis, peptide affinity assay, immunoprecipitation, immunoblot, and complementary split luciferase assay as well as mouse xenograft tumour model to investigate how the function of RAF is cooperatively regulated by Cdc37/Hsp90 chaperones and 14-3-3 scaffolds and how this regulatory machinery is evaded by prevalent non-V600 mutations. Results: We found that Cdc37/Hsp90 chaperones engaged with mature BRAF proteins promoted together with 14-3-3 scaffolds a switch of BRAF proteins from active open dimers into inactive close monomers. Most non-V600 mutations were enriched on or around the Cdc37/Hsp90-binding segments of BRAF, which impair association of CDc37/Hsp90 chaperones with BRAF and hence trap BRAF in active open conformation favouring dimerization. These BRAF mutants with high dimer propensity sustained a prolonged ERK signaling, and were effectively targeted by RAF dimer breaker plx8394 in vitro and in vivo. In contrast, CRAF and ARAF existed as immature monomers highly packaged with Cdc37/Hsp90 chaperones, which will be released upon dimerization driven by RAS-GTP binding with their N-terminus as well as 14-3-3 scaffold association with their C-terminus. Mature CRAF and ARAF dimers also sustained a prolonged ERK signaling as non-V600 BRAF mutants by virtue of absence of the C-terminal Cdc37/Hsp90-binding segment. Conclusions: Cdc37/Hsp90 chaperones and 14-3-3 scaffolds cooperatively facilitate the switch of RAF proteins from open active dimers to close inactive monomers. Non-V600 mutations disrupt this regulatory machinery, and trap RAF in dimers, which could be targeted by RAF dimer breakers.
Insights
Non-V600 BRAF mutations disrupt RAF protein regulation by Cdc37/Hsp90 chaperones and 14-3-3 scaffolds, trapping RAF in active dimers. These oncogenic RAF dimers can be targeted by specific RAF dimer breakers.
Area of Science:
- Molecular Cell Biology
- Cancer Biology
- Protein Regulation
Background:
- RAF kinases, especially BRAF, are frequent oncogenic targets in cancer.
- Mechanisms by which non-V600 BRAF mutations promote oncogenicity are not fully understood.
- RAF protein function is regulated by Cdc37/Hsp90 chaperones and 14-3-3 scaffolds.
Purpose of the Study:
- To investigate how Cdc37/Hsp90 chaperones and 14-3-3 scaffolds regulate RAF protein function.
- To elucidate how non-V600 BRAF mutations evade this regulatory machinery.
Main Methods:
- Utilized mutagenesis, peptide affinity assays, immunoprecipitation, and immunoblotting.
- Employed complementary split luciferase assays and a mouse xenograft tumor model.
- Investigated the interaction between RAF proteins, Cdc37/Hsp90, and 14-3-3 scaffolds.
Main Results:
- Cdc37/Hsp90 and 14-3-3 promote the switch of BRAF from active dimers to inactive monomers.
- Non-V600 mutations impair Cdc37/Hsp90 binding, trapping BRAF in active, dimerized conformations.
- These BRAF mutants and mature CRAF/ARAF dimers sustain prolonged ERK signaling and respond to RAF dimer breakers.
Conclusions:
- Cdc37/Hsp90 chaperones and 14-3-3 scaffolds are crucial for RAF inactivation.
- Non-V600 BRAF mutations disrupt this regulation, leading to persistent RAF dimerization and signaling.
- Targeting these RAF dimers with specific inhibitors represents a potential therapeutic strategy.
More Related Videos
06:44Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells
Published on: March 1, 2024
10:16Employing Digital Droplet PCR to Detect BRAF V600E Mutations in Formalin-fixed Paraffin-embedded Reference Standard Cell Lines
Published on: October 8, 2015
Related Concept Videos
The Ras Gene
Ras is a...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
MAPK Signaling Cascades
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Abnormal Proliferation